The top pick for marijuana addiction statistics is the National Survey on Drug Use and Health (NSDUH), run by the Substance Abuse and Mental Health Services Administration. It wins on the four criteria used to rank every source below: national sample size, whether the data rests on a clinical definition of cannabis use disorder rather than a single survey question, how often the numbers refresh, and whether results can be split by age group or by state. No other single source does all four.
One note before the numbers. "Addiction" is a lay term. The clinical term is cannabis use disorder, and every credible statistic you will find is built on that diagnosis.
What Counts as Cannabis Use Disorder in These Data
The DSM-5 merged cannabis abuse and cannabis dependence into one diagnosis and graded it mild, moderate, or severe depending on how many criteria a person meets. Surveys run before that change used the older DSM-IV categories. A trend line that crosses the switch is comparing two different yardsticks, which is the most common mistake in articles that quote marijuana addiction statistics.
marijuana addiction statistics
1. NSDUH (Top Pick)
NSDUH is an annual survey of Americans aged 12 and older. It reports past-month and past-year cannabis use, age of first use, and past-year cannabis use disorder, with state estimates for several measures. Recent releases put past-year cannabis use disorder in the low single digits as a share of the population aged 12 and older, and a higher share among people who used cannabis during the past year.
marijuana addiction statistics
- Pros: large national sample, consistent methodology across years, state and age breakdowns, free public data tables.
- Pros: built on DSM criteria, so it estimates disorder rather than use alone.
- Cons: self-reported, and people underreport behavior they see as stigmatized.
- Cons: misses people who are homeless outside shelters or incarcerated.
- Cons: the newest release typically lags the calendar by a year or more.
Use it when you need a defensible national or state prevalence figure, or when you want to compare age groups.
2. Monitoring the Future
Monitoring the Future, funded by the National Institute on Drug Abuse, surveys students in 8th, 10th, and 12th grades and follows panels of them into adulthood. It is the strongest source for trends in teen use, perceived risk, and age of first use.
- Pros: long unbroken time series going back decades, which makes trend reading easier than in shorter surveys.
- Pros: panel design follows the same people as they age, so you can see how adolescent use relates to adult outcomes.
- Cons: school-based sampling misses students who drop out, who tend to report higher use.
- Cons: it tracks use and attitudes more than clinical diagnosis, so it is a weak fit for disorder prevalence.
Use it when the question is about adolescents, generational shifts, or how risk perception moves before use rates do.
3. CDC and NCHS Surveillance
The Centers for Disease Control and Prevention pulls together survey data, emergency department records, and mortality files into public health summaries. It is less a primary survey of addiction and more a translator of other datasets.
- Pros: plain-language framing, useful context on health outcomes tied to cannabis, and links to state policy information.
- Pros: good starting point if you need a citation a general audience will accept.
- Cons: not a prevalence survey in its own right, so figures trace back to NSDUH or NCHS sources.
- Cons: updates are uneven across topics.
Use it for background, health framing, and numbers tied to emergency visits or poison center calls.
4. Cochrane Systematic Reviews
Cochrane reviews cover treatment, not prevalence. They assess whether psychosocial approaches such as cognitive behavioral therapy and contingency management reduce cannabis use, and they grade the strength of the evidence behind each conclusion.
- Pros: transparent methods, explicit risk-of-bias assessment, no marketing influence.
- Pros: the right place to check whether a treatment claim holds up.
- Cons: answers treatment questions, not "how many people are affected."
- Cons: review scope is narrow, so a single review will not settle a broad question.
Use it when you are evaluating a treatment or intervention claim rather than a prevalence number.
How to Read a Cannabis Statistic Without Being Misled
- Check the definition. A number about "marijuana addiction" that rests on one survey item is not the same as a DSM-based disorder estimate.
- Separate prevalence from incidence. How many people have it now is a different figure from how many develop it each year.
- Look at the denominator. A share of all adults and a share of past-year users can differ by an order of magnitude.
- Check the year and the survey version. Definitions and questionnaires change, and comparisons across those seams break.
- Read the confidence interval. Small subgroups, such as a single state or a narrow age band, carry wide margins.
Which Source Fits Your Question
- National or state prevalence of cannabis use disorder: NSDUH.
- Teen trends and age of first use: Monitoring the Future.
- Health outcomes and public framing: CDC and NCHS.
- Treatment effectiveness: Cochrane reviews.
Eden Cannabis operates in legal adult-use markets, and legal status does not change whether someone meets clinical criteria for cannabis use disorder. Consumer education and clear labeling sit alongside the public health data described here, and none of this is medical advice. If you are concerned about your own use, a clinician or a state health department resource is the place to start.